4565.T
Nxera Pharma Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 1,180.00
+2.61%Margins
Gross margin
62.6%
EBITDA margin
-12.0%
EBIT margin
-8.8%
Net margin
-29.1%
FCF margin
-16.3%
-15.7%
Return on equity
-7.5%
Return on assets
-3.6%
Return on invested capital
0.26x
Asset turnover
-JPY 4.9B
Cash from operations
JPY 128
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026